Apoptosis in the pathophysiology of diabetes mellitus

International Journal of Biochemistry and Cell Biology

Volumn 39, Issue 3, 2007, Pages 497-504

  Lee, Shao Chin ^a   Pervaiz, Shazib ^a,b,c  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Apoptosis; Diabetes; Genetic control; Mitosis; Pancreatic cells

Indexed keywords

INSULIN;

AMYLOIDOSIS; APOPTOSIS; AUTOIMMUNE DISEASE; CELL LOSS; CLINICAL FEATURE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; GENETIC SUSCEPTIBILITY; HUMAN; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; PANCREAS ISLET BETA CELL; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

APOPTOSIS; AUTOIMMUNITY; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INSULIN; INSULIN-SECRETING CELLS; MITOSIS; MODELS, BIOLOGICAL;

EID: 33846195875     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2006.09.007     Document Type: Review

References (48)

1. Allison J., Thomas H.E., Catterall T., et al. Transgenic expression of dominant-negative Fas-associated death domain protein in beta cells protects against Fas ligand-induced apoptosis and reduces spontaneous diabetes in nonobese diabetic mice. Journal of Immunology 175 (2005) 293-301
2. Babic I., Cherry E., and Fujita D. SUMO modification of Sam68 enhances its ability to repress cyclin D1 expression and inhibits its ability to induce apoptosis. Oncogene 25 (2006) 4955-4964
3. Babu S.R., Bao F., Roberts C., et al. Caspase 7 is a positional candidate gene for IDDM 17 in a Bedouin Arab family. Annals of the New York Academy of Sciences 1005 (2003) 340-343
4. Bosca L., and Hortelano S. Mechanisms of nitric oxide-dependent apoptosis: Involvement of mitochondrial mediators. Cell Signal 11 (1999) 239-244
5. Butler A., Jang J., Gurlo T., et al. Diabetes due to a progressive defect in beta-cell mass in rats transgenic for human islet amyloid polypeptide (HIP Rat): A new model for Type 2 diabetes. Diabetes 53 (2004) 1509-1516
6. Butler A., Janson J., Bonner-Weir S., et al. Beta-cell deficit and increased beta-cell apoptosis in humans with Type 2 diabetes. Diabetes 52 (2003) 102-110
7. Chang I., Cho N., Kim S., et al. Role of calcium in pancreatic islet cell death by IFN-gamma/TNF-alpha. Journal of Immunology 172 (2004) 7008-7014
8. Chen W., Salojin K., Mi Q., et al. Insulin-like growth factor (IGF)-I/IGF-binding protein-3 complex: Therapeutic efficacy and mechanism of protection against Type 1 diabetes. Endocrinology 145 (2004) 627-638
9. Cnop M., Welsh N., Jonas J., et al. Mechanisms of pancreatic {beta}-cell death in Type 1 and Type 2 diabetes: Many differences, few similarities. Diabetes 54 (2005) S97-S107
10. Contreras J., Smyth C., Bilbao G., et al. Simvastatin induces activation of the serine-threonine protein kinase AKT and increases survival of isolated human pancreatic islets. Transplantation 74 (2002) 1063-1069
11. Datta S., Dudek H., Tao X., et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91 (1997) 231-241
12. Elghazi L., Balcazar N., and Bernal-Mizrachi E. Emerging role of protein kinase B/Akt signaling in pancreatic β-cell mass and function. International Journal Biochemistry and Cell Biology 38 (2006) 689-695
13. Federici M., Hribal M., Perego L., et al. High glucose causes apoptosis in cultured human pancreatic islets of Langerhans: A potential role for regulation of specific Bcl family genes toward an apoptotic cell death program. Diabetes 50 (2001) 1290-1301
14. George S., Rochford J., Wolfrum C., et al. A family with severe insulin resistance and diabetes due to a mutation in AKT2. Science 304 (2004) 1325-1328
15. Green D. Apoptotic pathways: Ten minutes to dead. Cell 121 (2005) 671-674
16. Hoglund P., Mintern J., Waltzinger C., et al. Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes. Journal of Experimental Medicine 189 (1999) 331-339
17. Hokanson J., Kinney G., Cheng S., et al. Susceptibility to type 1 diabetes is associated with ApoCIII gene haplotypes. Diabetes 55 (2006) 834-838
18. Horikoshi M., Hara K., Ohashi J., et al. A polymorphism in the AMPKalpha2 subunit gene is associated with insulin resistance and type 2 diabetes in the Japanese population. Diabetes 55 (2006) 919-923
19. Ishihara H., Sasaoka T., Kagawa S., et al. Association of the polymorphisms in the 5′-untranslated region of PTEN gene with type 2 diabetes in a Japanese population. FEBS Letters 554 (2003) 450-454
20. Johannesen J., et al. Linkage of the human inducible nitric oxide synthase gene to type 1 diabetes. Journal of Clinical Endocrinology and Metabolism 86 (2001) 2792-2796
21. Johnson J., Han Z., Otani K., et al. RyR2 and calpain-10 delineate a novel apoptosis pathway in pancreatic islets. Journal of Biological Chemistry 279 (2004) 24794-24802
22. 2+-dependent beta cell death in type 1 diabetes. Proceedings of the National Academy of Sciences of the United States of America 101 (2004) 10090-10094
23. Kang E., Kim H., Nam M., et al. A novel 111/121 diplotype in the Calpain-10 gene is associated with type 2 diabetes. Journal of Human Genetics (2006) (Epub ahead of print)
24. Lee S., Pu Y., Chow C., et al. Diabetes in Hong Kong Chinese: Evidence for familial clustering and parental effects. Diabetes Care 23 (2000) 1365-1368
25. Lee S., Ko G., Li J., et al. Factors predicting the age when Type 2 diabetes is diagnosed in Hong Kong Chinese subjects. Diabetes Care 24 (2001) 646-649
26. Li J., Miller E., Ninomiya-Tsuji J., et al. AMP-activated protein kinase activates p38 mitogen-activated protein kinase by increasing recruitment of p38 MAPK to TAB1 in the ischemic heart. Circulation Research 97 (2005) 872-879
27. Lin C., Gurlo T., Haataja L., et al. Activation of peroxisome proliferator-activated receptor-gamma by rosiglitazone protects human islet cells against human islet amyloid polypeptide toxicity by a phosphatidylinositol 3′-kinase-dependent pathway. Journal of Clinical Endocrinology and Metabolism 90 (2005) 6678-6686
28. Lupi R., Dotta F., Marselli L., et al. Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: Evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated. Diabetes 51 (2002) 1437-1443
29. Maedler K., Spinas G., Lehmann R., et al. Glucose induces beta-cell apoptosis via upregulation of the Fas(CD95) receptor in human islets. Diabetes 50 (2001) 1683-1690
30. Marchetti P., Del Guerra S., Marselli L., et al. Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin. Journal of Clinical Endocrinology and Metabolism 89 (2004) 5535-5541
31. Masiello P. Animal models of Type 2 diabetes with reduced pancreatic β-cell mass. International Journal of Biochemistry and Cell Biology 38 (2006) 873-893
32. Nolsoe R., Hamid Y., Pociot F., et al. Association of a microsatellite in FASL to type II diabetes and of the FAS-670G>A genotype to insulin resistance. Genes and immunity (2006) (Epub ahead of print)
33. Petrovsky N., Silva D., Socha L., et al. The role of Fas(CD95) ligand in beta cell destruction in autoimmune diabetes of NOD mice. Annals of the New York Academy of Sciences 958 (2002) 204-208
34. Qu H., Bharaj B., Liu X., et al. Assessing the validity of the association between the SUMO4 M55V variant and risk of type 1 diabetes. Nature Genetics 37 (2005) 112
35. Reaven G. Role of insulin resistance in human disease. Diabetes 37 (1988) 1595-1607
36. Riachy R., Vandewalle B., Moerman E., et al. 1,25-Dihydroxyvitamin D3 protects human pancreatic islets against cytokine-induced apoptosis via down-regulation of the Fas receptor. Apoptosis 11 (2006) 151-159
37. Ritzel R., and Butler P. Replication increases beta-cell vulnerability to human islet amyloid polypeptide-induced apoptosis. Diabetes 52 (2003) 1701-1708
38. Rumora L., Hadzija M., Barisic K., et al. Amylin-induced cytotoxicity is associated with activation of caspase-3 and MAP kinases. Biological Chemistry 383 (2002) 1751-1758
39. Saldeen J. Cytokines induce both necrosis and apoptosis via a common Bcl-2-inhibitable pathway in rat insulin-producing cells. Endocrinology 141 (2000) 2003-2010
40. Scaffidi C., Fulda S., Srinivasan A., et al. Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 16 (1998) 1675-1687
41. Stassi G.D., De Maria R., Trucco G., et al. Nitric oxide primes pancreatic beta cells for Fas(CD95)-mediated destruction in insulin-dependent diabetes mellitus. Journal of Experimental Medicine 186 (1997) 1193-1200
42. Storling J., Binzer J., Andersson A., et al. Nitric oxide contributes to cytokine-induced apoptosis in pancreatic beta cells via potentiation of JNK activity and inhibition of Akt. Diabetologia 48 (2005) 2039-2050
43. Sun H., Lesche R., Li D., et al. PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway. Proceedings of the National Academy of Sciences of the United States of America 96 (1999) 6199-6204
44. Trudeau J., Dutz J., Arany E., et al. Neonatal beta-cell apoptosis: A trigger for autoimmune diabetes?. Diabetes 49 (2000) 1-7
45. Ueki K., Okada T., Hu J., et al. Total insulin and IGF-I resistance in pancreatic beta cells causes overt diabetes. Nature Genetics 38 (2006) 583-588
46. Xiao D., and Singh S. Diallyl trisulfide, a constituent of processed garlic, inactivates Akt to trigger mitochondrial translocation of BAD and caspase-mediated apoptosis in human prostate cancer cells. Carcinogenesis 27 (2006) 533-540
47. Zhang S., Liu J., Saafi E., et al. Induction of apoptosis by human amylin in RINm5F islet beta-cells is associated with enhanced expression of p53 and p21WAF1/CIP1. FEBS Letters 455 (1999) 315-320
48. Zhou X., Liu Y., Payne G., et al. Growth factors inactivate the cell death promoter BAD by phosphorylation of its BH3 domain on Ser155. The Journal of Biological Chemistry 275 (2002) 25046-25051